Download PDF
Der Nuklearmediziner 2014; 37(01): 30-37
DOI: 10.1055/s-0034-1368699
Zukünftige Indikationen der PET/CT
© Georg Thieme Verlag KG Stuttgart · New York

FDG-PET/CT bei Fieber ungeklärter Genese

FDG PET/CT in Fever of Unknown Origin
D. Hellwig
1   Klinik für Nuklearmedizin, Universitätsklinikum des Saarlandes, Homburg
› Author Affiliations
Further Information

Publication History

Publication Date:
31 March 2014 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Fieber ungeklärter Genese ist eine diagnostische Herausforderung. Infektionen, Entzündungen, maligne Tumoren und eine Vielzahl weiterer Erkrankungen können Fieber hervorrufen. Das Radiopharmakon F-18-FDG reichert sich in Entzündungen an, weshalb die arzneimittelrechtliche Zulassung seit 2010 dieses Indika­tionsgebiet umfasst. Die hochsensitive FDG-PET/CT-Diagnostik übertrifft die Detektionsrate herkömmlicher radiologischer und nuklearmedizinischer Verfahren zur Entzündungssuche und kann daher einen wichtigen Beitrag zur Diagnostik bei Fieber ungeklärter Genese leisten. Neben der hohen Sensitivität ist ein wesentlicher Vorteil der PET/CT-Diagnostik, dass man vollstän­dige Ganzkörper-Untersuchungen durchführen kann. Dadurch erfasst man ein breiteres Diagnosespektrum und auch seltene Erkrankungen, welche Fieber ungeklärter Genese verursachen. Darüberhinaus hat die Entzündungsdiagnostik mittels FDG-PET/CT das Potenzial, diagnostische Abläufe bei der stationären Versorgung schwerer Erkrankungsverläufe zu beschleunigen.

Abstract

Fever of unknown origin is a diagnostic challenge. Infections, inflammations, malignant tumors and many further diseases can cause fever. The radiopharmaceutical F-18 FDG accumulates in inflammations which is why its regulatory drug approval includes this indication since 2010. The highly sensitive FDG PET/CT examination exceeds the diagnostic performance of conventional radiological and nuclear medicine procedures for the detection of inflammations and can therefore make an important contribution to the diagnosis of fever of unknown origin. Besides its high sensitivity a major advantage of FDG PET/CT imaging is its ability to perform extended whole body examinations. From this, a broader spectrum and even rare causes for fever of unknown origin are detected. Moreover, FDG PET/CT helps to guide further diagnostic tests for the evaluation of fever of unknown origin and has the potential to speed up diagnostic procedures in the inpatient care of severe courses.

Schlüsselwörter

FDG - PET/CT - Fieber ungeklärter Genese

Key words

FDG - PET/CT - fever of unknown origin
 

  • Literatur

  • 1 Amberger CC, Dittmann H, Overkamp D et al. Large vessel vasculitis as cause of fever of unknown origin (FUO) or systemic inflammation. Diagnosis using 18-F-fluor-2-deoxy-D-glucose positron emission tomography ((18)F-FDG-PET). Z Rheumatol 2005; 1: 32-39
    PubMedGoogle Scholar
  • 2 Bleeker-Rovers CP, Vos FJ, Mudde AH et al. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mol Imaging 2007; 5: 694-703
    PubMedGoogle Scholar
  • 3 Blockmans D, Knockaert D, Maes A et al. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001; 2: 191-196
    PubMedGoogle Scholar
  • 4 Brodmann M, Lipp RW, Passath A et al. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 2004; 2: 241-242
    PubMedGoogle Scholar
  • 5 Buysschaert I, Vanderschueren S, Blockmans D et al. Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med 2004; 3: 151-156
    PubMedGoogle Scholar
  • 6 Castaigne C, Tondeur M, de Wit S et al. Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective study. Nucl Med Commun 2009; 1: 41-47
    PubMedGoogle Scholar
  • 7 Durack DT, Street AC. Fever of unknown origin – reexamined and redefined. Curr Clin Top Infect Dis 1991; 35-51
    PubMedGoogle Scholar
  • 8 Hayakawa K, Ramasamy B, Chandrasekar PH. Fever of unknown origin: an evidence-based review. Am J Med Sci 2012; 4: 307-316
    PubMedGoogle Scholar
  • 9 Keidar Z, Gurman-Balbir A, Gaitini D et al. Fever of unknown origin: the role of 18F-FDG PET/CT. J Nucl Med 2008; 12: 1980-1985
    PubMedGoogle Scholar
  • 10 Keidar Z, Nitecki S. FDG-PET in prosthetic graft infections. Semin Nucl Med 2013; 5: 396-402
    PubMedGoogle Scholar
  • 11 Kjaer A, Lebech AM, Eigtved A et al. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging 2004; 5: 622-626
    PubMedGoogle Scholar
  • 12 Knockaert DC, Dujardin KS, Bobbaers HJ. Long-term follow-up of patients with undiagnosed fever of unknown origin. Arch Intern Med 1996; 6: 618-620
    PubMedGoogle Scholar
  • 13 Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on. J Intern Med 2003; 3: 263-275
    PubMedGoogle Scholar
  • 14 Knockaert DC, Vanneste LJ, Bobbaers HJ. Recurrent or episodic fever of unknown origin. Review of 45 cases and survey of the literature. Medicine (Baltimore) 1993; 3: 184-196
    PubMedGoogle Scholar
  • 15 Kouijzer IJ, Bleeker-Rovers CP, Oyen WJ. FDG-PET in fever of unknown origin. Semin Nucl Med 2013; 5: 333-339
    PubMedGoogle Scholar
  • 16 Martin C, Castaigne C, Tondeur M et al. Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study. HIV Med 2013; 8: 455-462
    PubMedGoogle Scholar
  • 17 Meller J, Altenvoerde G, Munzel U et al. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med 2000; 11: 1617-1625
    PubMedGoogle Scholar
  • 18 Meller J, Sahlmann CO, Gurocak O et al. FDG-PET in patients with fever of unknown origin: the importance of diagnosing large vessel vasculitis. Q J Nucl Med Mol Imaging 2009; 1: 51-63
    PubMedGoogle Scholar
  • 19 Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 2007; 1: 35-45
    PubMedGoogle Scholar
  • 20 Meller J, Strutz F, Siefker U et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003; 5: 730-736
    PubMedGoogle Scholar
  • 21 Petersdorf RG. Fever of unknown origin. An old friend revisited. Arch Intern Med 1992; 1: 21-22
    PubMedGoogle Scholar
  • 22 Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore) 1961; 1-30
    PubMedGoogle Scholar
  • 23 Qiu L, Chen Y. The role of 18F-FDG PET or PET/CT in the detection of fever of unknown origin. Eur J Radiol 2012; 11: 3524-3529
    PubMedGoogle Scholar
  • 24 Quarles van Ufford HM, Zoon PJ, van Waes PF et al. Solitary splenic metastasis in a patient with a malignant melanoma diagnosed with F-18-FDG PET scanning. Clin Nucl Med 2005; 8: 582-583
    PubMedGoogle Scholar
  • 25 Roth AR, Basello GM. Approach to the adult patient with fever of unknown origin. Am Fam Physician 2003; 11: 2223-2228
    PubMedGoogle Scholar
  • 26 Salzberger B, Müller-Schilling M, Fleck M. Fever of unknown origin. Z Rheumatol 2013; 3: 255-266
    PubMedGoogle Scholar
  • 27 Seshadri N, Sonoda LI, Lever AM et al. Superiority of 18F-FDG PET compared to 111In-labelled leucocyte scintigraphy in the evaluation of fever of unknown origin. J Infect 2012; 1: 71-79
    PubMedGoogle Scholar
  • 28 Vos FJ, Kullberg BJ, Sturm PD et al. Metastatic infectious disease and clinical outcome in Staphylococcus aureus and Streptococcus species bacteremia. Medicine (Baltimore) 2012; 2: 86-94
    PubMedGoogle Scholar